Haemonetics | HAE - Umlaufvermögen

Aktienkurs
59.93
Täglich Wechseln
0.31 0.52%
Monatlich
7.15%
Jährlich
-4.13%
Q2 Prognose
58.65




Umlaufvermögen Veränderung Datum
Avanos Medical USD 355.4M 4M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cerus USD 167.13M 1.41M 2025-09
Cooper Companies USD 2.13B 27.4M 2025-12
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Globus Medical USD 2.13B 201.25M 2025-12
Haemonetics USD 943.67M 43.99M 2025-12
ICU Medical USD 1.19B 16.74M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
Masimo USD 926M 122.3M 2025-12
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.04B 54.62M 2025-12
Neogen USD 590M 15.42M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Plus Therapeutics USD 15.17M 2.42M 2025-12
Quidel USD 1.45B 80.6M 2025-12
ResMed USD 3.82B 193.06M 2025-12
STAAR Surgical USD 311.54M 9.66M 2025-12
Steris USD 2.29B 179.9M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 75.99M 5.31M 2025-06
Teleflex USD 1.94B 47.65M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
US Physical Therapy USD 139.99M 1.56M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12